Patents by Inventor Bruce E. Johnson

Bruce E. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11009508
    Abstract: The present invention provides methods of detecting cancer using biomarkers.
    Type: Grant
    Filed: January 23, 2019
    Date of Patent: May 18, 2021
    Assignees: Dana-Farber Cancer Institute, Inc., The General Hospital Corporation, Board of Regents of the University of Texas System
    Inventors: Kwok-Kin Wong, Bruce E. Johnson, Pasi A. Janne, Hongbin Ji, Nabeel Bardeesy, Norman E. Sharpless, Diego H. Castrillon
  • Publication number: 20210017604
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Application
    Filed: April 21, 2020
    Publication date: January 21, 2021
    Applicants: The General Hospital Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Daphne Winifred BELL, Daniel A. HABER, Pasi Antero JANNE, Bruce E. JOHNSON, Thomas J. LYNCH, Matthew MEYERSON, Juan Guillermo PAEZ, William R. SELLERS, Jeffrey E. SETTLEMAN, Raffaella SORDELLA
  • Patent number: 10841241
    Abstract: An intelligent placement engine generates a placement map that provides a configuration for deploying a service based at least in part, on one or more configuration parameters. A data center in which the service is to be hosted is defined using a data center definition, while the service is defined using a service definition. The configuration parameters include estimated probabilities calculated based on estimated resource consumption data. The resource consumption data is estimated based at least in part on historical data distributions.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: November 17, 2020
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Michael Anthony Wise, Alex Lee, Bruce E. Johnson
  • Patent number: 10669589
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: June 2, 2020
    Assignees: The General Hospital Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Daphne Winifred Bell, Daniel A. Haber, Pasi Antero Janne, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson, Juan Guillermo Paez, William R. Sellers, Jeffrey E. Settleman, Raffaella Sordella
  • Publication number: 20190207869
    Abstract: An intelligent placement engine generates a placement map that provides a configuration for deploying a service based at least in part, on one or more configuration parameters. A data center in which the service is to be hosted is defined using a data center definition, while the service is defined using a service definition. The configuration parameters include estimated probabilities calculated based on estimated resource consumption data. The resource consumption data is estimated based at least in part on historical data distributions.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Inventors: Michael Anthony Wise, Alex Lee, Bruce E. Johnson
  • Publication number: 20190145977
    Abstract: The present invention provides methods of detecting cancer using biomarkers.
    Type: Application
    Filed: January 23, 2019
    Publication date: May 16, 2019
    Inventors: Kwok-Kin WONG, Bruce E. JOHNSON, Pasi A. JANNE, Hongbin JI, Nabeel BARDEESY, Norman E. SHARPLESS, Diego H. Castrillon
  • Patent number: 10243879
    Abstract: An intelligent placement engine generates a placement map that provides a configuration for deploying a service based at least in part, on one or more configuration parameters. A data center in which the service is to be hosted is defined using a data center definition, while the service is defined using a service definition. The configuration parameters include estimated probabilities calculated based on estimated resource consumption data. The resource consumption data is estimated based at least in part on historical data distributions.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: March 26, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael Anthony Wise, Alex Lee, Bruce E Johnson
  • Patent number: 10172581
    Abstract: The present invention provides method of assessing tumor growth.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: January 8, 2019
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Mizuki Nishino, Bruce E. Johnson, Hiroto Hatabu, Suzanne E. Dahlberg
  • Publication number: 20180251860
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 6, 2018
    Applicants: The General Hospital Corporation, Dana-Farber Cancer Institute, Inc.
    Inventors: Daphne Winifred BELL, Daniel A. HABER, Pasi Antero JANNE, Bruce E. JOHNSON, Thomas J. LYNCH, Matthew MEYERSON, Juan Guillermo PAEZ, William R. SELLERS, Jeffrey E. SETTLEMAN, Raffaella SORDELLA
  • Patent number: 10000815
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: June 19, 2018
    Assignees: THE GENERAL HOSPITAL CORPORATION, DANA-FARBER CANCER INSTITUTE, INC
    Inventors: Daphne Winifred Bell, Daniel A. Haber, Pasi Antero Janne, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson, Juan Guillermo Paez, William R. Sellers, Jeffrey E. Settleman, Raffaella Sordella
  • Publication number: 20160269319
    Abstract: An intelligent placement engine generates a placement map that provides a configuration for deploying a service based at least in part, on one or more configuration parameters. A data center in which the service is to be hosted is defined using a data center definition, while the service is defined using a service definition. The configuration parameters include estimated probabilities calculated based on estimated resource consumption data. The resource consumption data is estimated based at least in part on historical data distributions.
    Type: Application
    Filed: March 13, 2015
    Publication date: September 15, 2016
    Inventors: Michael Anthony Wise, Alex Lee, Bruce E. Johnson
  • Publication number: 20160220208
    Abstract: The present invention provides method of assessing tumor growth.
    Type: Application
    Filed: September 9, 2014
    Publication date: August 4, 2016
    Inventors: Mizuki Nishino, Bruce E. Johnson, Hiroto Hatabu, Suzanne E. Dahlberg
  • Patent number: 9119379
    Abstract: Methods, devices, and systems are provided for identifying estrus or onset of estrus in a female animal.
    Type: Grant
    Filed: October 4, 2012
    Date of Patent: September 1, 2015
    Inventors: William B. Yancey, Linda C. Frank, Bruce E. Johnson
  • Publication number: 20150176081
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Application
    Filed: March 4, 2015
    Publication date: June 25, 2015
    Inventors: Daphne Winifred BELL, Daniel A. HABER, Pasi Antero JANNE, Bruce E. JOHNSON, Thomas J. LYNCH, Matthew MEYERSON, Juan Guillermo PAEZ, William R. SELLERS, Jeffrey E. SETTLEMAN, Raffaella SORDELLA
  • Patent number: 9055414
    Abstract: Text messaging between cell phones, computer applications, and/or other communication devices has become a common means of communication. Because of the prevalence of text messaging, robust text message processing may be facilitated through text messaging pipelines. Accordingly, as provided herein, a text messaging pipeline may be configured according to a pipeline module list. The pipeline module list may be constructed through an online service wherein predefined pipeline modules and/or user defined pipeline modules may be selected to create the pipeline module list. The configured text messaging pipeline may provide customized text message processing. For example, a user may select a spam filter, a translator, and/or other pipeline modules to configure a text messaging pipeline. Text message workflow (e.g., SMS messages that are sent and/or received by a computer application associated with the text messaging pipeline) may be processed through the text messaging pipeline.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: June 9, 2015
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Raman Narayanan, Bruce E. Johnson, Rajendra H. Vishnumurty, Ming Liu
  • Patent number: 9035036
    Abstract: Disclosed herein are methods and reagents for determining the responsiveness of cancer to an epidermal growth factor receptor (EGFR) targeting treatment. The detection of these mutations will allow for the administration of gefitinib, erlotinib and other tyrosine kinase inhibitors to those patients most likely to respond to the drug.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: May 19, 2015
    Assignees: The General Hospital, Dana-Farber Cancer Institute, Inc.
    Inventors: Daphne Winifred Bell, Daniel A. Haber, Pasi Antero Janne, Bruce E. Johnson, Thomas J. Lynch, Matthew Meyerson, Juan Guillermo Paez, William R. Sellers, Jeffrey E. Settleman, Raffaella Sordella
  • Patent number: 8996423
    Abstract: Current embodiments provide for authorization and payment of an online commercial transaction between a purchaser and a merchant including verification of an identity of the purchaser and verification of an ability of the purchaser to pay for the transaction, where the identity provider and the payment provider are often different network entities. Other embodiments also provide for protocols, computing systems, and other mechanisms that allow for identity and payment authentication using a mobile module, which establishes single or multilevel security over an untrusted network (e.g., the Internet). Still other embodiments also provide for a three-way secure communication between a merchant, consumer, and payment provider such that sensitive account information is opaque to the merchant, yet the merchant is sufficiently confident of the consumer's ability to pay for requested purchases.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: March 31, 2015
    Assignee: Microsoft Corporation
    Inventors: Bruce E. Johnson, Chung Webster-Lam
  • Publication number: 20140351146
    Abstract: Current embodiments provide for authorization and payment of an online commercial transaction between a purchaser and a merchant including verification of an identity of the purchaser and verification of an ability of the purchaser to pay for the transaction, where the identity provider and the payment provider are often different network entities. Other embodiments also provide for protocols, computing systems, and other mechanisms that allow for identity and payment authentication using a mobile module, which establishes single or multilevel security over an untrusted network (e.g., the Internet). Still other embodiments also provide for a three-way secure communication between a merchant, consumer, and payment provider such that sensitive account information is opaque to the merchant, yet the merchant is sufficiently confident of the consumer's ability to pay for requested purchases.
    Type: Application
    Filed: August 12, 2014
    Publication date: November 27, 2014
    Inventors: Bruce E. Johnson, Chung Webster-Lam
  • Patent number: 8024711
    Abstract: A tool for analyzing software. The tool identifies calls to framework components made from within one or more application programs. The information may be processed to indicate usage of framework components. This usage information may be aggregated over a pool of application programs to derive statistical usage information for each component in the framework, allowing components to be selected for inclusion in a compact framework. Usage information may also be used for scheduling development tasks so that the most widely used framework components are developed first or to estimate the amount of development required to modify an application program for execution against a target framework.
    Type: Grant
    Filed: August 10, 2005
    Date of Patent: September 20, 2011
    Assignee: Microsoft Corporation
    Inventors: Benjamin Albahari, Bruce E. Johnson, Fernando L. Fanton
  • Patent number: 7945949
    Abstract: A developer can provide complex services to existing legacy applications using one or more components configured to tap into a service abstraction framework. In one implementation, for example, a developer of a remote service provider adds one or more authentication attributes to the remote service provider, and further creates a local client driver that incorporates a client proxy. When a legacy application generates a function request (e.g., to print, send a text message, initiate a voice communication), the client proxy intercepts the request through an appropriate communication subsystem, and relays the request to the server proxy. The server proxy determines the extent to which authentication measures may be required. If required, the client proxy can initiate out-of-band processing with various authentication managers to validate/process the request at the remote service provider.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: May 17, 2011
    Assignee: Microsoft Corporation
    Inventor: Bruce E. Johnson